Skip to main content
. 2021 Mar 31;16(3):e0243291. doi: 10.1371/journal.pone.0243291

Table 2. Discharge and respiratory outcomes (highest requirement during admission) for all patients with known disposition categorized by sex, race, ethnicity and Elixhauser comorbidities.

Discharged No Oxygen Low Flow High Flow Noninvasive Invasive Discharged Alive Expired
n 2152 430 809 511 73 329 1847 305
Sex
 Male (%) 1122 (52.1) 196 (45.6) 379 (46.8) 296 (57.9) 36 (49.3) 215 (65.3) 947 (51.3) 175 (57.4)
Race (%)
 American Indian or Alaska Native <10 (<0.5) 0 (0.0) <5 (<0.6) 0 (0.0) 0 (0.0) 0 (0.0) <10 (<0.5) 0 (0.0)
 Asian 44 (2.0) 8 (1.9) 13 (1.6) 13 (2.5) <5 (<6.8) <10 (<3.0) 38 (2.1) <10 (<3.3)
 Black 544 (25.3) 110 (25.6) 209 (25.8) 111 (21.7) 14 (19.2) 100 (30.4) 475 (25.7) 69 (22.6)
 Hawaiian/Pacific Islander <10 (<0.5) 0 (0.0) <5 (<0.6) <5 (<1.0) 0 (0.0) <10 (<3.0) <10 (<0.5) <10 (<3.3)
 Other 497 (23.1) 107 (24.9) 166 (20.5) 110 (21.5) 15 (20.5) 99 (30.1) 454 (24.6) 43 (14.1)
 Unknown/Not Stated 37 (1.7) 7 (1.6) 19 (2.3) <5 (<1.0) <5 (<6.8)) <10 (<3.0) 37 (2.0) 0 (0.0)
 White 1021 (47.4) 198 (46.0) 397 (49.1) 272 (53.2) 41 (56.2) 113 (34.3) 836 (45.3) 185 (60.7)
Ethnicity (%)
 Hispanic or Latino 560 (26.0) 125 (29.1) 196 (24.2) 111 (21.7) 18 (24.7) 110 (33.4) 511 (27.7) 49 (16.1)
 Not Hispanic or Latino 1557 (72.4) 302 (70.2) 596 (73.7) 393 (76.9) 55 (75.3) 211 (64.1) 1308 (70.8) 249 (81.6)
 Unknown/Not Stated 35 (1.6) 3 (0.7) 17 (2.1) 7 (1.4) 0 (0.0) 8 (2.4) 28 (1.5) 7 (2.3)
Age (%)
 18–34 146 (6.8) 73 (17.0) 35 (4.3) 18 (3.5) 4 (5.5) 16 (4.9) 145 (7.9) 1 (0.3)
 35–44 181 (8.4) 61 (14.2) 58 (7.2) 28 (5.5) 4 (5.5) 30 (9.1) 176 (9.5) 5 (1.6)
 45–54 257 (11.9) 54 (12.6) 104 (12.9) 48 (9.4) 8 (11.0) 43 (13.1) 248 (13.4) 9 (3.0)
 55–64 435 (20.2) 67 (15.6) 166 (20.5) 101 (19.8) 14 (19.2) 87 (26.4) 399 (21.6) 36 (11.8)
 65–74 402 (18.7) 60 (14.0) 171 (21.1) 81 (15.9) 17 (23.3) 73 (22.2) 351 (19.0) 51 (16.7)
 75–84 373 (17.3) 58 (13.5) 137 (16.9) 104 (20.4) 18 (24.7) 56 (17.0) 278 (15.1) 95 (31.1)
 85+ 358 (16.6) 57 (13.3) 138 (17.1) 131 (25.6) 8 (11.0) 24 (7.3) 250 (13.5) 108 (35.4)
Comorbidity (%)
 AIDS/HIV 32 (1.5) 3 (0.7) 13 (1.6) 8 (1.6) 3 (4.1) 5 (1.5) 28 (1.5) 4 (1.3)
 Alcohol abuse 175 (8.1) 35 (8.1) 68 (8.4) 39 (7.6) 6 (8.2) 27 (8.2) 151 (8.2) 24 (7.9)
 Blood loss anemia 142 (6.6) 16 (3.7) 62 (7.7) 37 (7.2) 5 (6.8) 22 (6.7) 98 (5.3) 44 (14.4)
 Cardiac arrhythmias 801 (37.2) 134 (31.2) 318 (39.3) 215 (42.1) 27 (37.0) 107 (32.5) 639 (34.6) 162 (53.1)
 Chronic pulmonary disease 716 (33.3) 110 (25.6) 281 (34.7) 195 (38.2) 32 (43.8) 98 (29.8) 587 (31.8) 129 (42.3)
 Coagulopathy 264 (12.3) 39 (9.1) 109 (13.5) 64 (12.5) 7 (9.6) 45 (13.7) 201 (10.9) 63 (20.7)
 Congestive heart failure 493 (22.9) 61 (14.2) 197 (24.4) 145 (28.4) 19 (26.0) 71 (21.6) 380 (20.6) 113 (37.0)
 Deficiency anemia 407 (18.9) 65 (15.1) 162 (20.0) 106 (20.7) 19 (26.0) 55 (16.7) 323 (17.5) 84 (27.5)
 Depression 636 (29.6) 101 (23.5) 253 (31.3) 182 (35.6) 27 (37.0) 73 (22.2) 526 (28.5) 110 (36.1)
 Diabetes, complicated 623 (28.9) 87 (20.2) 232 (28.7) 159 (31.1) 27 (37.0) 118 (35.9) 499 (27.0) 124 (40.7)
 Diabetes, uncomplicated 809 (37.6) 127 (29.5) 305 (37.7) 199 (38.9) 33 (45.2) 145 (44.1) 658 (35.6) 151 (49.5)
 Drug abuse 172 (8.0) 34 (7.9) 60 (7.4) 41 (8.0) 8 (11.0) 29 (8.8) 151 (8.2) 21 (6.9)
 Fluid and electrolyte disorders 904 (42.0) 149 (34.7) 338 (41.8) 242 (47.4) 41 (56.2) 134 (40.7) 721 (39.0) 183 (60.0)
 Hypertension, complicated 615 (28.6) 78 (18.1) 237 (29.3) 176 (34.4) 25 (34.2) 99 (30.1) 478 (25.9) 137 (44.9)
 Hypertension, uncomplicated 1386 (64.4) 234 (54.4) 537 (66.4) 365 (71.4) 46 (63.0) 204 (62.0) 1133 (61.3) 253 (83.0)
 Hypothyroidism 448 (20.8) 66 (15.3) 183 (22.6) 121 (23.7) 14 (19.2) 64 (19.5) 353 (19.1) 95 (31.1)
 Liver disease 283 (13.2) 56 (13.0) 104 (12.9) 69 (13.5) 10 (13.7) 44 (13.4) 232 (12.6) 51 (16.7)
 Lymphoma 29 (1.3) 6 (1.4) 10 (1.2) 10 (2.0) 73 (100.0) 3 (0.9) 23 (1.2) 6 (2.0)
 Metastatic cancer 140 (6.5) 24 (5.6) 55 (6.8) 42 (8.2) 4 (5.5) 15 (4.6) 111 (6.0) 29 (9.5)
 Obesity 682 (31.7) 112 (26.0) 264 (32.6) 161 (31.5) 29 (39.7) 116 (35.3) 582 (31.5) 100 (32.8)
 Other neurological disorders 541 (25.1) 66 (15.3) 225 (27.8) 153 (29.9) 20 (27.4) 77 (23.4) 414 (22.4) 127 (41.6)
 Paralysis 117 (5.4) 9 (2.1) 46 (5.7) 35 (6.8) 7 (9.6) 20 (6.1) 96 (5.2) 21 (6.9)
 Peptic ulcer disease, excluding bleeding 113 (5.3) 22 (5.1) 46 (5.7) 32 (6.3) 2 (2.7) 11 (3.3) 90 (4.9) 23 (7.5)
 Peripheral vascular disorders 521 (24.2) 69 (16.0) 200 (24.7) 155 (30.3) 25 (34.2) 72 (21.9) 400 (21.7) 121 (39.7)
 Psychoses 206 (9.6) 32 (7.4) 80 (9.9) 67 (13.1) 7 (9.6) 20 (6.1) 166 (9.0) 40 (13.1)
 Pulmonary circulation disorders 225 (10.5) 36 (8.4) 73 (9.0) 65 (12.7) 10 (13.7) 41 (12.5) 165 (8.9) 60 (19.7)
 Renal failure 513 (23.8) 79 (18.4) 186 (23.0) 144 (28.2) 19 (26.0) 85 (25.8) 392 (21.2) 121 (39.7)
 Rheumatoid arthritis/collagen vascular diseases 174 (8.1) 27 (6.3) 74 (9.1) 40 (7.8) 8 (11.0) 25 (7.6) 139 (7.5) 35 (11.5)
 Solid tumor without metastasis 313 (14.5) 43 (10.0) 122 (15.1) 88 (17.2) 14 (19.2) 46 (14.0) 249 (13.5) 64 (21.0)
 Valvular disease 527 (24.5) 74 (17.2) 229 (28.3) 141 (27.6) 17 (23.3) 66 (20.1) 420 (22.7) 107 (35.1)
 Weight loss 356 (16.5) 59 (13.7) 140 (17.3) 107 (20.9) 8 (11.0) 42 (12.8) 277 (15.0) 79 (25.9)

Expired includes those that expired in the ED without known respiratory outcomes.